The Leverage Trap: The Subtle Ways Healthcare Founders Lose Power Once Buyers Engage
By Diwakar Sinha Most founders think leverage is something you gain during negotiation. It isn’t. Leverage is something you either protect or give away the moment buyers show up. And here’s the part no one tells you: You don’t lose leverage in the big moments. You lose it in the small ones. In a rushed […]
The Hidden Cost of Waiting: How Delayed Preparation Quietly Erodes Your Valuation Long Before You Go to Market
By Diwakar Sinha Founders rarely lose valuation because their business is weak. They lose valuation because they waited too long to fix what buyers care about. At Polaris Healthcare Partners, we see this pattern constantly. A founder decides they’re “ready to sell,” and only then begins preparing for the process. But by that point, the […]
What Buyers Actually Pay For: The Real Drivers of Valuation Most Founders Overlook
By Diwakar Sinha Great businesses don’t always command great valuations. Here’s what to do about it. Founders often assume valuation is a simple equation: grow revenue, grow EBITDA, get a higher multiple. But that’s not how buyers think. Buyers don’t pay for the business you feel you’ve built, they pay for the business they can […]
The Psychology of Diligence: Why Even the Strongest Founders Feel the Pressure
By Diwakar Sinha Every founder expects diligence to be a paperwork exercise. It isn’t. It’s a psychological one. If going to market is the “storytelling” phase of a sale, diligence is the moment where buyers test whether your story holds up under pressure. And that pressure is real. Even the most confident, seasoned founders feel […]
The Founder Blind Spots That Quietly Kill Valuation
By Diwakar Sinha Every founder believes they know their business better than anyone else, and they’re right. But that deep familiarity comes with a hidden cost: you stop seeing the things buyers will notice immediately. But the best teams help you surface those things long before buyers. At Polaris Healthcare Partners, we sit across from […]
Transacting Your Practice: Choosing Between Holdco Equity and JV/Practice-Level Equity
By Diwakar Sinha Thinking in multiples of EBITDA is just the starting point. The real question is this: which scenario drives greater value for you? A 6× multiple at the holding company level on a 5% CAGR business, or a 7× multiple on a practice-level JV growing 10%? The answer isn’t obvious, and that’s exactly […]